Stocks and Investing Stocks and Investing
Fri, October 28, 2022

Paul Knight Maintained (WST) at Buy with Decreased Target to $350 on, Oct 28th, 2022


Published on 2024-10-27 23:44:21 - WOPRAI, Paul Knight
  Print publication without navigation


Paul Knight of Keybanc, Maintained "West Pharmaceutical Services, Inc." (WST) at Buy with Decreased Target from $400 to $350 on, Oct 28th, 2022.

Paul has made no other calls on WST in the last 4 months.



There is 1 other peer that has a rating on WST. Out of the 1 peers that are also analyzing WST, all agrees with Paul's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jacob Johnson of "Stephens & Co." Maintained at Hold with Increased Target to $345 on, Friday, July 29th, 2022
Contributing Sources